Mr. Ilan Sobel reports

BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS

Bioharvest Sciences Inc. has granted 100,000 incentive stock options to an employee. The stock options granted are exercisable to purchase a common share of the company at a price of 22.5 cents per share for a term of 10 years and will vest quarterly over a two-year period.

In addition, the company has granted 476,000 consultants options to the consultants providing services under the agreement with MZ North America announced by the company in a news release issued on Feb. 15, 2024. The options will vest on May 13, 2024, and are valid for two years. Each option is exercisable to acquire a common share at a price of 22.5 cents per share.

About Bioharvest Sciences Inc.

Bioharvest Sciences is a fast-growing biotech firm listed on the Canadian Securities Exchange. Bioharvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. Bioharvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals -- nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based active pharmaceutical ingredients (APIs) that focus on specific medical indications.

We seek Safe Harbor.